Literature DB >> 12195446

Relationship between urinary symptoms and disease-related parameters in multiple sclerosis.

I Araki1, M Matsui, K Ozawa, M Nishimura, S Kuno, T Saida.   

Abstract

OBJECTIVE: To find the prevalence of voiding dysfunction in patients with multiple sclerosis and to examine the relationship between the voiding dysfunction and various parameters of the disease (disease severity, disease duration, lesion site, age and sex).
METHODS: Using the International prostate symptom score, lower urinary tract symptoms were quantitatively evaluated in all patients with multiple sclerosis who had visited our neurological department during three months. The lesion site in the central nervous system was determined by a combination of neurological and magnetic resonance imaging findings.
RESULTS: Of the 47 patients who had completed the questionnaire, 25 (53 %) were considered to have symptomatic voiding dysfunction. Even at early stage of the disability, 6 of 19 (32 %) patients were symptomatic. Eight (17 %) patients had irritative urinary symptoms alone, whereas 9 (19 %) patients had obstructive urinary symptoms alone. The irritative and obstructive symptoms were concomitant in 10 (21 %) patients. Compared with reports from Western countries, the ratio of obstructive symptoms to irritative symptoms was high in Japan. The degree of irritative symptoms was well correlated with the disease severity, whereas the correlation of obstructive symptoms with the disease severity was less significant. Irritative symptoms also showed a weak correlation with the disease duration, but obstructive symptoms did not. Among the lesion sites in the central nervous system, only the presence of the spinal cord lesion was related to the degree of urinary symptoms. Urinary symptoms were not significantly influenced by the age or the sex. Quality of life was disturbed by urinary symptoms, and this disturbance paralleled the disease severity.
CONCLUSION: Urinary symptoms, especially irritative symptoms, reflect the condition of the disease. Thus, the quantified urinary symptoms may assist neurological diagnosis.

Entities:  

Mesh:

Year:  2002        PMID: 12195446     DOI: 10.1007/s00415-002-0775-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  11 in total

Review 1.  Evaluation of lower urinary tract symptoms in multiple sclerosis patients: Review of the literature and current guidelines.

Authors:  Shachar Moshe Aharony; Ornella Lam; Jacques Corcos
Journal:  Can Urol Assoc J       Date:  2017 Jan-Feb       Impact factor: 1.862

Review 2.  Neurogenic lower urinary tract dysfunction: evaluation and management.

Authors:  Katarina Ivana Tudor; Ryuji Sakakibara; Jalesh N Panicker
Journal:  J Neurol       Date:  2016-07-11       Impact factor: 4.849

3.  Quality of life in women with multiple sclerosis and overactive bladder syndrome.

Authors:  Giuseppe Quarto; Riccardo Autorino; Antonio Gallo; Marco De Sio; Massimo D'Armiento; Sisto Perdonà; Rocco Damiano
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-05-13

4.  The impact of pontine disease on lower urinary tract symptoms in patients with multiple sclerosis.

Authors:  Steven J Weissbart; Dasha Pechersky; Anna Malykhina; Thomas Bavaria; Lisa Parrillo; Lily A Arya; Michel Bilello; Alan J Wein; Ariana L Smith
Journal:  Neurourol Urodyn       Date:  2016-01-06       Impact factor: 2.696

5.  Maximal bladder capacity is a positive predictor of response to desmopressin treatment in patients with MS and nocturia.

Authors:  Athanasios Zahariou; Maria Karamouti; George Karagiannis; Polyanthi Papaioannou
Journal:  Int Urol Nephrol       Date:  2007-07-03       Impact factor: 2.370

Review 6.  Autonomic dysfunction in multiple sclerosis.

Authors:  Carl-Albrecht Haensch; Johannes Jörg
Journal:  J Neurol       Date:  2006-02       Impact factor: 4.849

Review 7.  Animal modeling of lower urinary tract dysfunction associated with multiple sclerosis: Part I: Justification of the mouse model for MS research.

Authors:  Ramalakshmi Ramasamy; Phillip P Smith
Journal:  Neurourol Urodyn       Date:  2021-03-14       Impact factor: 2.696

Review 8.  PART 2: Mouse models for multiple sclerosis research.

Authors:  Ramalakshmi Ramasamy; Phillip P Smith
Journal:  Neurourol Urodyn       Date:  2021-03-19       Impact factor: 2.696

9.  Quality of life among patients with multiple sclerosis and voiding dysfunction: a cross-sectional study.

Authors:  Fatemeh Nazari; Vahid Shaygannejad; Mehrdad Mohammadi Sichani; Marjan Mansourian; Valiollah Hajhashemi
Journal:  BMC Urol       Date:  2020-06-03       Impact factor: 2.264

10.  Increased risk of erectile dysfunction in men with multiple sclerosis: an Italian cross-sectional study.

Authors:  Raffaele Balsamo; Davide Arcaniolo; Marco Stizzo; Ester Illiano; Riccardo Autorino; Franca Natale; Elisabetta Costantini; Rocco Damiano; Marco De Sio
Journal:  Cent European J Urol       Date:  2017-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.